KATIE CREMATA: Open Payments
NPI 1184157968 · PORT ORANGE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,035 in 95 payments from 16 companies in 2025. Trend: 2023 $1,608 · 2024 $1,816 · 2025 $2,035
Food & beverage: $2,025Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $451 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $281 |
| Madrigal Pharmaceuticals | 8 | $190 |
| Phathom Pharmaceuticals, Inc. | 4 | $173 |
| Aimmune Therapeutics, Inc. | 8 | $153 |
| Janssen Biotech, Inc. | 9 | $147 |
| Ardelyx, Inc. | 6 | $127 |
| GENZYME CORPORATION | 6 | $121 |
| QOL Medical, LLC | 4 | $117 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $90 |
Products named: ENTYVIO, RINVOQ, REZDIFFRA, VOQUEZNA, ZENPEP, DUPIXENT, SKYRIZI, TREMFYA.
Industry payments across FL — which companies pay providers there.
